TNFα promotes proliferation of oligodendrocyte progenitors and remyelination

被引:813
作者
Arnett, HA
Mason, J
Marino, M
Suzuki, K
Matsushima, GK
Ting, JPY [1 ]
机构
[1] Univ N Carolina, Lineberger Comprehens Canc Ctr, Sch Med CB7295, Chapel Hill, NC 27599 USA
[2] Univ N Carolina, Curriculum Neurobiol, Chapel Hill, NC 27599 USA
[3] Mem Sloan Kettering Canc Ctr, Ludwig Inst, New York, NY 10017 USA
[4] Univ N Carolina, Dept Pathol & Lab Med, Chapel Hill, NC 27599 USA
[5] Univ N Carolina, Dept Microbiol & Immunol, Chapel Hill, NC 27599 USA
关键词
D O I
10.1038/nn738
中图分类号
Q189 [神经科学];
学科分类号
071006 ;
摘要
Here we used mice lacking tumor necrosis factor-alpha (TNF alpha) and its associated receptors to study a model of demyelination and remyelination in which these events could be carefully controlled using a toxin, cuprizone. Unexpectedly, the lack of TNF alpha led to a significant delay in remyelination as assessed by histology, immunohistochemistry for myelin proteins and electron microscopy coupled with morphometric analysis. Failure of repair correlated with a reduction in the pool of proliferating oligodendrocyte progenitors (bromodeoxyuridine-labeled NG2(+) cells) followed by a reduction in the number of mature oligodendrocytes. Analysis of mice lacking TNF receptor 1 (TNFR1) or TNFR2 indicated that TNFR2, not TNFR1, is critical to oligodendrocyte regeneration. This unexpected reparative role for TNF alpha in the CNS is important for understanding oligodendrocyte regeneration/proliferation, nerve remyelination and the design of new therapeutics for demyelinating diseases.
引用
收藏
页码:1116 / 1122
页数:7
相关论文
共 48 条
[1]   Oligodendrocyte apoptosis and primary demyelination induced by local TNF/p55TNF receptor signaling in the central nervous system of transgenic mice - Models for multiple sclerosis with primary oligodendrogliopathy [J].
Akassoglou, K ;
Bauer, J ;
Kassiotis, G ;
Pasparakis, M ;
Lassmann, H ;
Kollias, G ;
Probert, L .
AMERICAN JOURNAL OF PATHOLOGY, 1998, 153 (03) :801-813
[2]   TNF neutralization in MS - Results of a randomized, placebo-controlled multicenter study [J].
Arnason, BGW ;
Jacobs, G ;
Hanlon, M ;
Clay, BH ;
Noronha, ABC ;
Auty, A ;
Davis, B ;
Nath, A ;
Bouchard, JP ;
Belanger, C ;
Gosselin, F ;
Thibault, M ;
Duquette, P ;
Bourgoin, P ;
DuBois, R ;
Girard, M ;
Ebers, GC ;
Rice, GPA ;
Vandervoort, MK ;
Francis, GS ;
Duncan, L ;
Lapierre, Y ;
Freedman, MS ;
Christie, SN ;
Rabinovitch, HE ;
Patry, D ;
Murphy, WF ;
Peters, S ;
McGuiness, SD ;
Murray, TJ ;
Bhan, V ;
Maxner, CE ;
Van Dorpe, R ;
Oger, JJ ;
Nelson, J ;
Morrison, W ;
Bogle, N ;
Beall, S ;
Vorobeychick, G ;
Hiltbrunner, AV ;
Bock, J ;
Habil ;
Lesslauer, W ;
Li, DKB ;
Paty, DW ;
Zhao, GJ .
NEUROLOGY, 1999, 53 (03) :457-465
[3]   Apoptosis control by death and decoy receptors [J].
Ashkenazi, A ;
Dixit, VM .
CURRENT OPINION IN CELL BIOLOGY, 1999, 11 (02) :255-260
[4]   A CRUCIAL ROLE FOR NEUROTROPHIN-3 IN OLIGODENDROCYTE DEVELOPMENT [J].
BARRES, BA ;
RAFF, MC ;
GAESE, F ;
BARTKE, I ;
DECHANT, G ;
BARDE, YA .
NATURE, 1994, 367 (6461) :371-375
[5]   Cytokine regulation of secondary lymphoid organ development [J].
Chaplin, DD ;
Fu, YX .
CURRENT OPINION IN IMMUNOLOGY, 1998, 10 (03) :289-297
[6]   Myelination in the absence of galactocerebroside and sulfatide: Normal structure with abnormal function and regional instability [J].
Coetzee, T ;
Fujita, N ;
Dupree, J ;
Shi, R ;
Blight, A ;
Suzuki, K ;
Suzuki, K ;
Popko, B .
CELL, 1996, 86 (02) :209-219
[7]   Gene therapy for chronic relapsing experimental allergic encephalomyelitis using cells expressing a novel soluble p75 dimeric TNF receptor [J].
Croxford, JL ;
Triantaphyllopoulos, KA ;
Neve, RM ;
Feldmann, M ;
Chernajovsky, Y ;
Baker, D .
JOURNAL OF IMMUNOLOGY, 2000, 164 (05) :2776-2781
[8]  
Declercq W, 1998, J IMMUNOL, V161, P390
[9]   Differential expression, cytokine modulation, and specific functions of type-1 and type-2 tumor necrosis factor receptors in rat glia [J].
Dopp, JM ;
MackenzieGraham, A ;
Otero, GC ;
Merrill, JE .
JOURNAL OF NEUROIMMUNOLOGY, 1997, 75 (1-2) :104-112
[10]   Identification of autoantibodies associated with myelin damage in multiple sclerosis [J].
Genain, CP ;
Cannella, B ;
Hauser, SL ;
Raine, CS .
NATURE MEDICINE, 1999, 5 (02) :170-175